ALLO
NASDAQ
US
Allogene Therapeutics, Inc. - Common Stock
$2.48
▼ $-0.08
(-3.13%)
Vol 4.3M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$307.9M
ROE
-57.8%
Margin
-269835.0%
D/E
0.00
Beta
0.58
52W
$1–$4
Wall Street Consensus
21 analysts · Apr 20267
Strong Buy
11
Buy
2
Hold
1
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
REPL
Replimune Group Inc
$762.5M
DSGN
Design Therapeutics Inc
$534.3M
GYRE
Gyre Therapeutics Inc
P/E 96.5
$641.7M
PURR
Hyperliquid Strategies Inc
PRME
Prime Medicine Inc
$626.4M
OCGN
Ocugen Inc
$421.6M
MDXG
MiMedx Group Inc
P/E 24.6
$1.0B
IRWD
Ironwood Pharmaceuticals Inc
P/E 19.2
$548.2M
PROK
Prokidney Corp
$673.9M
TECX
Tectonic Therapeutic Inc
$390.4M
Earnings
Beat rate: 100.0%
Next Report
May 11, 2026
EPS Estimate: $-0.20
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.20 | — | — |
| Dec 2025 | $-0.22 | $-0.17 | +$0.05 |
| Sep 2025 | $-0.23 | $-0.19 | +$0.04 |
| Jun 2025 | $-0.28 | $-0.23 | +$0.05 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -58.6% | -58.6% | -58.6% | -58.6% | -57.8% | -57.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -269835.0% | -269835.0% | -269835.0% | -269835.0% | -269835.0% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.92 | 8.92 | 8.92 | 8.92 | 8.19 | 8.19 |
Key Ratios
ROA (TTM)
-43.1%
P/S (TTM)
1562.84
P/B
1.1
EPS (TTM)
$-0.98
CF/Share
$-2.12
Rev Growth 3Y
-91.7%
52W High
$3.78
52W Low
$0.86
$0.86
52-Week Range
$3.78
How does ALLO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ALLO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1562.8
▲
12062%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.1
▼
57%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ALLO profitability vs Biotechnology peers
ROE
-57.8%
▲
14%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-269835.0%
▼
94001%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-43.1%
▲
8%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
ALLO financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.2
▲
84%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.6
▼
40%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ALLO fundamentals radar
ALLO
Peer median
Industry
ALLO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ALLO vs peers: key metrics
Latest News
Iran Allows Iraqi Ships To Use Strait Of Hormuz As Total Weekly …
ZeroHedge · Apr 05
Goodbye mrbrightside416: Google allows users to alter quirky Gmail addresses
The Guardian · Apr 02
San Francisco First Since 2022 to See Gas at $6 a Gallon: …
Yahoo Finance · Mar 31
Iran Allowing 20 More Ships Through Strait Of Hormuz, Pakistan Says
ZeroHedge · Mar 29
O'Keefe Catches Skid Row Fraudsters Paying Homeless People To Forge Signatures On …
ZeroHedge · Mar 26